1. Design and Characterization of a Twin Ribozyme for Potential Repair of a Deletion Mutation within the OncogenicCTNNB1-ΔS45 mRNA
- Author
-
Irene Zieten, Darko Balke, Sabine Müller, Anne Strahl, and Oliver Müller
- Subjects
Spliceosome ,DNA Repair ,Molecular Sequence Data ,Biochemistry ,Drug Discovery ,RNA, Catalytic ,RNA, Messenger ,General Pharmacology, Toxicology and Pharmaceutics ,Gene ,beta Catenin ,Ligase ribozyme ,RNA Cleavage ,Pharmacology ,Base Sequence ,biology ,Organic Chemistry ,Ribozyme ,RNA repair ,Molecular biology ,Kinetics ,Drug Design ,Mutation ,biology.protein ,Molecular Medicine ,Mammalian CPEB3 ribozyme ,Hairpin ribozyme ,Gene Deletion ,VS ribozyme - Abstract
RNA repair is an emerging strategy for gene therapy. Conventional gene therapy typically relies on the addition of the corrected DNA sequence of a defective gene to restore gene function. As an additional option, RNA repair allows alteration of the sequence of endogenous messenger RNAs (mRNAs). mRNA sequence alteration is either facilitated by intracellular spliceosome machinery or by the intrinsic catalytic activity of trans-acting ribozymes. Previously we developed twin ribozymes, derived from the hairpin ribozyme, by tandem duplication and demonstrated their potential for patchwise RNA repair. Herein we describe the development of such a twin ribozyme for potential repair of a deletion mutation in the oncogenic CTNNB1-ΔS45 mRNA. We demonstrate that hairpin ribozyme units within the twin ribozyme can be adapted to efficiently cleave/ligate non-consensus substrates by introduction of compensatory mutations in the ribozyme. Thus, we show the twin ribozyme mediated repair of truncated CTNNB1 transcripts (up to 1000 nt length). Repair of the entire CTNNB1-ΔS45 mRNA, although apparently possible in general, is hampered in vitro by the secondary structure of the transcript.
- Published
- 2014